According to the aforementioned information and regarding the fact that WT is one of the major renal cancers of pediatric age, we decided to perform a retrospective cross-sectional study with the main purpose of investigating the expression of CD133 and CD56/NCAM in WT and their association with prognostic factors and survival. This evidence concerns the gene NCAM1 and renal carcinoma.